Lucid Diligence Brief - BioPharma

Roche Ivy Tech Laboratory Workforce Partnership | Lucid Diligence Brief

Roche Diagnostics and Ivy Tech launch an Indiana laboratory workforce…


Lucid Diligence Brief - BioPharma

Johnson & Johnson Firefly Bio Acquisition | Lucid Diligence Brief

Johnson & Johnson's $1 billion Firefly Bio acquisition highlights a…


Lucid Diligence Brief - Tech

Massive Bio and GELL Partnership | Lucid Diligence Brief

Massive Bio and GELL have launched a strategic partnership to expand AI-enabled…


Lucid Diligence Brief - BioPharma

Harbour BioMed and Sinopharm Innovation Consortium Expands Biologics Strategy | Lucid Diligence Brief

Harbour BioMed partners with Sinopharm to establish an innovation consortium…


Lucid Diligence Brief - BioPharma

Evogene and ELEO Oral PCSK9 Collaboration | Lucid Diligence Brief

Evogene and ELEO Oral PCSK9 discovery collaboration launches as Merck’s…


Lucid Diligence Brief - BioPharma

AdaptHealth Diabetes Health Divestiture to Cardinal Health | Lucid Diligence Brief

AdaptHealth exits its Diabetes Health business in a $235 million deal as…


Lucid Diligence Brief - Tech

Excalipoint Therapeutics and DP Technology Partnership | Lucid Diligence Brief

Excalipoint Therapeutics and DP Technology have partnered to develop an agentic…


Lucid Diligence Brief - Tech

Nucleai-University of Glasgow Partnership Expands Spatial AI Platform | Lucid Diligence Brief

Nucleai broadened its University of Glasgow collaboration to expand academic…


Lucid Diligence Brief - BioPharma

Servier Completes Edgewise Muscular Dystrophy Acquisition | Lucid Diligence Brief

Servier Completes the Edgewise Muscular Dystrophy Acquisition and Adds…


Lucid Diligence Brief - BioPharma

Warburg Pincus PANTHERx Rare Acquisition | Lucid Diligence Brief

Warburg Pincus to acquire control of PANTHERx Rare, backing expansion of the…


Lucid Diligence Brief - BioPharma

United Therapeutics’ Thymmune acquisition | Lucid Diligence Brief

United Therapeutics adds Thymmune’s iPSC thymic-cell platform to its…


Lucid Diligence Brief - Tech

Insilico Takeda AI Drug Discovery Deal | Lucid Diligence Brief

Insilico and Takeda test whether Pharma.AI can convert discovery speed into…


Privacy Preference Center